Logo
AZN logo
AstraZeneca PLC
AZN
157.88 (-1.39%) 2.19
Market cap
$244.88(B)
Earnings date
Oct-30-2026
Category
Sector
Health Care
Industry
Pharmaceuticals
AstraZeneca PLC a biopharmaceutical company focuses on the discovery development manufacture and commercialization of prescription medicines. The company offers Imjudo Datroway Iressa Tagrisso Imfinzi Lynparza Calquence Enhertu Orpathys Truqap Zoladex Faslodex Crestor Andexxa Onglyza Symlin XIGDUO XR Atacand Atacand HCT Atacand Plus Farxiga/Forxiga Plendil Modip Splendil Munobal Flodil Tenormin Tenormine Prenormine Atenol Zestril Brilinta/Brilique Komboglyze Qtern Wainua Byetta Lokelma Seloken ZOK Toprol-XL Betaloc ZOK XIGDUO Accolate Accoleit Vanticon Bricanyl Respules Eklira Genuair/Tudorza/Bretaris Pulmicort Turbuhaler Symbicort Turbuhaler Airsupra Bricanyl Turbuhaler Fasenra Rhinocort Tezspire Bevespi Aerosphere Daliresp/Daxas Oxis Turbuhaler Saphnelo Breztri Aerosphere Duaklir Genuair Pulmicort Respules and Symbicort pMDI. It also provides Beyfortus Kavigale Evusheld Fluenz/FluMist Synagis Kanuma Ultomiris Koselugo Voydeya Soliris Strensiq Nexium and other medicines. The company offers its products for ocology cardiovascular renal and metabolism respiratory & immunology vaccines and immune and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom the Americas rest of Europe Asia Africa and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge the United Kingdom.
EV: $283.92(B)
Total Equity: $50.37(B)
Debt/Equity: 0.64
Dividend/share: $3.2
Div. yield: 2.05%
P/E: 23.42
Forward P/E: 15.54
P/FCF: 22.95
P/S: 3.99
P/B: 4.87
EPS: $6.7
EPS (fwd): $10.2
FCF/share: $6.9
Revenue/share: $39.6
Book value/share: $32.4
ROIC: 12.5%
ROA: 8.6%
ROE: 21.7%
Margins: Gross | Op. | Net
81.7% | 22.0% | 17.0%
0.0%of Portfolio
My holdings
Day change
Total change
Overview Valuation Growth Financials & KPIsCompetitors & Peer Comparison Ownership ToolsAll

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.05%
Institutions: 64.93%
Other: 35.02%

Institutional ownership

3.33% Investor AB2.93% Vanguard Capital Manag...2.23% Capital International ...2.18% NORGES BANK1.94% Capital World Investor...1.86% FMR, LLC1.84% Wellington Management ...1.66% Legal & General Group ...1.24% JPMORGAN CHASE & CO1.21% Vanguard Asset Managem...44.51% Others

Trading Summary

In the past year, insiders have bought a net of $10.15(M).

Total insider buys: $10.21(M)
Total insider sells: $53622

In the past year, Congress members have bought a net of $8001.

Total congressional buys (avg): $32002
Total congressional sells (avg): $24002

Based on the reported ranges: buys $4004–$60000, sells $3003–$45000.

Insider transactions

$0.002026-11$0.00
$0.002026-10$0.00
$0.002026-09$10.21(M)
$0.002026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$0.002026-01$0.00
$536222025-12$0.00
$0.002025-11$0.00
DateSharesTotal ($)Price ($)NameTitle
Buy2026-09-1460,0009,798,900163.3Soriot (Pascal)
Buy2026-09-142,500408,930163.6Demare (Michel)
Sell2025-12-1829753,622180.5Rahman (Nazneen)

Congressional trading

$0.002026-11$0.00
$0.002026-10$0.00
$0.002026-09$0.00
$0.002026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$0.002026-01$0.00
$0.002025-12$16001
$0.002025-11$8001
DatePoliticianPartyChamberAmount ($)
Buy2025-12-18Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Buy2025-12-08Julia LetlowRHouse$1,001 - $15,000
Buy2025-11-19Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Sell2025-10-31Lisa C. McClainRHouse$1,001 - $15,000
Buy2025-10-21Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Sell2025-09-23Val T. HoyleDHouse$1,001 - $15,000
Sell2025-09-23Val T. HoyleDHouse$1,001 - $15,000
(C) PEVALUATOR
About
Terms & privacy
Price charts & news courtesy of TradingView
Blog
Contact